About Biofrontera
Biofrontera is a company based in Leverkusen (Germany) founded in 1997.. The company has 93 employees as of December 31, 2024. Biofrontera has completed 1 acquisition, including Cutanea Life Sciences. Biofrontera offers products and services including Photodynamic Therapy Products and Topical Antibiotics. Biofrontera operates in a competitive market with competitors including Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others.
- Headquarter Leverkusen, Germany
- Employees 93 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofrontera Inc.
-
Annual Revenue
$37.32 M9.54as on Dec 31, 2024
-
Net Profit
$-17.76 M11.78as on Dec 31, 2024
-
EBITDA
$-16.06 M20.83as on Dec 31, 2024
-
Latest Funding Round
$11 M (USD), Post-IPO
Jun 27, 2025
-
Investors
NRW
& 1 more
-
Employee Count
93
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biofrontera
Biofrontera is a publicly listed company on the NASDAQ with ticker symbol BFRI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biofrontera
Biofrontera offers a comprehensive portfolio of products and services, including Photodynamic Therapy Products and Topical Antibiotics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for pre-cancerous skin lesions using light-based therapy.
Medications for bacterial infections like impetigo.
Unlock access to complete
Funding Insights of Biofrontera
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $11.0M
-
First Round
First Round
(18 Feb 2004)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Post-IPO - Biofrontera | Valuation |
investors |
|
| Feb, 2024 | Amount | Post-IPO - Biofrontera | Valuation |
investors |
|
| Nov, 2021 | Amount | Post-IPO - Biofrontera | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofrontera
Biofrontera has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NRW and Rosalind Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides investment management for life sciences and biotech funds to investors worldwide.
|
Founded Year | Domain | Location | |
|
Government programs access and development services are provided by NRW.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofrontera
Biofrontera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cutanea Life Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for skin disorders like acne and psoriasis are developed.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biofrontera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofrontera Comparisons
Competitors of Biofrontera
Biofrontera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| domain | founded_year | HQ Location |
Skin care products are developed and manufactured by SkinMedica.
|
|
| domain | founded_year | HQ Location |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofrontera
Frequently Asked Questions about Biofrontera
When was Biofrontera founded?
Biofrontera was founded in 1997 and raised its 1st funding round 7 years after it was founded.
Where is Biofrontera located?
Biofrontera is headquartered in Leverkusen, Germany. It is registered at Leverkusen, North Rhine-westphalia, Germany.
How many employees does Biofrontera have?
As of Dec 31, 2024, the latest employee count at Biofrontera is 93.
What is the annual revenue of Biofrontera?
Annual revenue of Biofrontera is $37.32M as on Dec 31, 2024.
What does Biofrontera do?
Biofrontera was founded in 1997 in Leverkusen, Germany, and operates within the dermatology sector. Solutions are offered for the sale and distribution of drugs, medical devices, and medical cosmetics focused on the care and treatment of skin diseases. The lead product, Ameluz, is utilized as a prescription drug for treating squamous cell carcinoma in situ. Additional dermatological items, including creams, gels, and scalp tonics, have been developed for consumer use.
Who are the top competitors of Biofrontera?
Biofrontera's top competitors include Revance Therapeutics, Dermavant and Collplant.
What products or services does Biofrontera offer?
Biofrontera offers Photodynamic Therapy Products and Topical Antibiotics.
Is Biofrontera publicly traded?
Yes, Biofrontera is publicly traded on NASDAQ under the ticker symbol BFRI.
How many acquisitions has Biofrontera made?
Biofrontera has made 1 acquisition, including Cutanea Life Sciences.
Who are Biofrontera's investors?
Biofrontera has 2 investors. Key investors include NRW, and Rosalind Advisors.
What is Biofrontera's ticker symbol?
The ticker symbol of Biofrontera is BFRI on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.